{
  "author": {
    "name": "Bryan Statham",
    "webUrl": "/author/profile/bryan-statham/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2020/08/07/drug-pricing-legislation-and-the-impact-on-self-insurers-pharmacy-spend/",
        "title": "Drug pricing legislation and the impact on self-insurers' pharmacy spend",
        "byline": "Bryan Statham",
        "kicker": "Expert Opinion",
        "prettyDate": "August 07, 2020",
        "timeToRead": "7 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/02/DrugCosts2.jpg",
          "width": "600",
          "height": "401"
        },
        "authors": [
          {
            "webUrl": "/author/profile/bryan-statham/",
            "name": "Bryan Statham"
          }
        ],
        "kickerNode": [
          {
            "uri": "/expert-opinion/",
            "sectionName": "Expert Opinion"
          }
        ],
        "summary": "Legislation on drug price reform may be slowed, but it's important to understand the potential impact of the bills on the table.",
        "body": null
      }
    ]
  }
}